Annual CFO
-$7.80 M
-$1.86 M-31.34%
December 31, 2023
Summary
- As of February 10, 2025, AGE annual cash flow from operations is -$7.80 million, with the most recent change of -$1.86 million (-31.34%) on December 31, 2023.
- During the last 3 years, AGE annual CFO has risen by +$17.00 thousand (+0.22%).
Performance
AGE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$2.05 M
-$188.00 K-10.09%
December 31, 2023
Summary
- As of February 10, 2025, AGE quarterly cash flow from operations is -$2.05 million, with the most recent change of -$188.00 thousand (-10.09%) on December 31, 2023.
- Over the past year, AGE quarterly CFO has dropped by -$731.00 thousand (-55.34%).
Performance
AGE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$7.80 M
-$731.00 K-10.34%
December 31, 2023
Summary
- As of February 10, 2025, AGE TTM cash flow from operations is -$7.80 million, with the most recent change of -$731.00 thousand (-10.34%) on December 31, 2023.
- Over the past year, AGE TTM CFO has dropped by -$1.86 million (-31.34%).
Performance
AGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AGE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.3% | -55.3% | -31.3% |
| 3 y3 years | +0.2% | -26.7% | +0.2% |
| 5 y5 years | +2.4% | -0.3% | +23.2% |
AGE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +31.3% | +0.7% | +66.0% | at low | +31.3% | +0.7% |
| 5 y | 5-year | +31.3% | +30.3% | +66.0% | +28.2% | +31.3% | +30.3% |
| alltime | all time | +31.3% | +30.3% | +66.0% | +34.5% | +289.0% | +30.3% |
AgeX Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$7.80 M(+31.3%) | -$2.05 M(+10.1%) | -$7.80 M(+10.3%) |
| Sep 2023 | - | -$1.86 M(-7.7%) | -$7.07 M(+9.8%) |
| Jun 2023 | - | -$2.02 M(+8.3%) | -$6.44 M(+4.4%) |
| Mar 2023 | - | -$1.86 M(+41.2%) | -$6.17 M(+3.9%) |
| Dec 2022 | -$5.94 M(-24.4%) | -$1.32 M(+6.9%) | -$5.94 M(-5.2%) |
| Sep 2022 | - | -$1.24 M(-29.2%) | -$6.26 M(-9.4%) |
| Jun 2022 | - | -$1.75 M(+6.7%) | -$6.91 M(+0.8%) |
| Mar 2022 | - | -$1.64 M(-0.7%) | -$6.86 M(-12.7%) |
| Dec 2021 | -$7.86 M(+0.5%) | -$1.65 M(-12.6%) | -$7.86 M(+0.3%) |
| Sep 2021 | - | -$1.88 M(+11.2%) | -$7.83 M(-0.1%) |
| Jun 2021 | - | -$1.69 M(-35.6%) | -$7.83 M(-6.6%) |
| Mar 2021 | - | -$2.63 M(+62.3%) | -$8.38 M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$7.82 M(-23.1%) | -$1.62 M(-14.2%) | -$7.82 M(-9.2%) |
| Sep 2020 | - | -$1.89 M(-15.8%) | -$8.61 M(-5.3%) |
| Jun 2020 | - | -$2.24 M(+8.7%) | -$9.09 M(-5.4%) |
| Mar 2020 | - | -$2.06 M(-14.4%) | -$9.61 M(-5.5%) |
| Dec 2019 | -$10.16 M(+27.1%) | -$2.41 M(+1.6%) | -$10.16 M(+3.7%) |
| Sep 2019 | - | -$2.37 M(-14.0%) | -$9.79 M(+6.4%) |
| Jun 2019 | - | -$2.76 M(+5.4%) | -$9.21 M(+6.9%) |
| Mar 2019 | - | -$2.62 M(+28.0%) | -$8.61 M(+7.7%) |
| Dec 2018 | -$8.00 M(+27.2%) | -$2.05 M(+14.8%) | -$8.00 M(+34.4%) |
| Sep 2018 | - | -$1.78 M(-17.5%) | -$5.95 M(+42.8%) |
| Jun 2018 | - | -$2.16 M(+7.8%) | -$4.17 M(+107.8%) |
| Mar 2018 | - | -$2.00 M | -$2.00 M |
| Dec 2017 | -$6.29 M | - | - |
FAQ
- What is AgeX Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for AgeX Therapeutics?
- What is AgeX Therapeutics annual CFO year-on-year change?
- What is AgeX Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly CFO year-on-year change?
- What is AgeX Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for AgeX Therapeutics?
- What is AgeX Therapeutics TTM CFO year-on-year change?
What is AgeX Therapeutics annual cash flow from operations?
The current annual CFO of AGE is -$7.80 M
What is the all time high annual CFO for AgeX Therapeutics?
AgeX Therapeutics all-time high annual cash flow from operations is -$5.94 M
What is AgeX Therapeutics annual CFO year-on-year change?
Over the past year, AGE annual cash flow from operations has changed by -$1.86 M (-31.34%)
What is AgeX Therapeutics quarterly cash flow from operations?
The current quarterly CFO of AGE is -$2.05 M
What is the all time high quarterly CFO for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly cash flow from operations is -$1.24 M
What is AgeX Therapeutics quarterly CFO year-on-year change?
Over the past year, AGE quarterly cash flow from operations has changed by -$731.00 K (-55.34%)
What is AgeX Therapeutics TTM cash flow from operations?
The current TTM CFO of AGE is -$7.80 M
What is the all time high TTM CFO for AgeX Therapeutics?
AgeX Therapeutics all-time high TTM cash flow from operations is -$2.00 M
What is AgeX Therapeutics TTM CFO year-on-year change?
Over the past year, AGE TTM cash flow from operations has changed by -$1.86 M (-31.34%)